Literature DB >> 29107650

Molecular characterization and antibiotic resistance of Streptococcus dysgalactiae subspecies equisimilis isolated from patients with streptococcal toxic shock syndrome.

T Ikebe1, R Okuno2, M Sasaki3, Y Kanda3, H Otsuka4, R Kawahara5, H Ohya6, M Suzuki6, K Uchida7, H Nihonmatsu8, M Ohnishi9.   

Abstract

Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multiorgan failure, and high mortality. Although STSS is mainly caused by Streptococcus pyogenes, group G streptococcus identified as S. dysgalactiae subsp. equisimilis (SDSE) causing STSS has also been reported; however, no study has analyzed >100 isolates of SDSE causing STSS. Therefore, we characterized the emm genotype of 173 SDSE isolates obtained from STSS patients in Japan during 2014-2016 and performed antimicrobial susceptibility testing using the broth microdilution method and emm gene typing. The predominant emm genotype was found to be stG6792, followed by stG485, stG245, stG10, stG6, and stG2078. These six genotypes constituted more than 75% of the STSS isolates. The proportion of each emm genotype in STSS isolates correlated with that in invasive isolates previously reported. We found that 16.2% of the isolates showed clindamycin resistance. The proportion of clindamycin-resistant SDSE isolates was significantly higher than that of S. pyogenes isolates. Thus, while treating STSS caused by SDSE, it is necessary to consider the possibility of clindamycin resistance and to ensure judicious use of the drug.
Copyright © 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Streptococcal toxic shock syndrome; Streptococcus dysgalactiae subspecies equisimilis; emm genotype

Mesh:

Substances:

Year:  2017        PMID: 29107650     DOI: 10.1016/j.jiac.2017.09.013

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  3 in total

1.  Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections.

Authors:  Yoshihiro Fujiya; Kayoko Hayakawa; Yoshiaki Gu; Kei Yamamoto; Momoko Mawatari; Satoshi Kutsuna; Nozomi Takeshita; Yasuyuki Kato; Shuzo Kanagawa; Norio Ohmagari
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

2.  Colonization of β-hemolytic streptococci in patients with erysipelas-a prospective study.

Authors:  Kristina Trell; Sofia Rignér; Marcelina Wierzbicka; Bo Nilson; Magnus Rasmussen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-10       Impact factor: 3.267

3.  In-hospital mortality among patients with invasive non-group A β-hemolytic Streptococcus treated with clindamycin combination therapy: a nationwide cohort study.

Authors:  Shoichiro Hamada; Mikio Nakajima; Richard H Kaszynski; Ryosuke Kumazawa; Hiroki Matui; Kiyohide Fushimi; Hideaki Goto; Yoshihiro Yamaguchi; Hideo Yasunaga
Journal:  Acute Med Surg       Date:  2021-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.